Literature DB >> 17626016

v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.

Yahao Bu1, Irwin H Gelman.   

Abstract

SSeCKS (Src-suppressed C kinase substrate), also called gravin/AKAP12, is a large scaffolding protein with metastasis suppressor activity. Two major isoforms of SSeCKS are expressed in most cell and tissue types under the control of two independent promoters, designated alpha and beta, separated by 68 kb. SSeCKS transcript and protein levels are severely decreased in Src- and Ras-transformed fibroblasts and in many epithelial tumors. By dissecting its promoters with progressive deletion analysis, we identified the sequence between -106 and -49 in the alpha proximal promoter as the minimal v-Src-responsive element, which contains E- and GC-boxes bound by USF1 and Sp1/Sp3, respectively. Both E- and GC-boxes are crucial for v-Src-responsive and basal promoter activities. v-Src does not alter USF1 binding levels at the E-box, but it increases Sp1/Sp3 binding to the GC-box despite no change in their cellular protein abundance. SSeCKS alpha and beta transcript levels in v-Src/3T3 cells can be restored by treatment with the histone deacetylase inhibitor, trichostatin A, but not with the DNA demethylation agent, 5-azacytidine. Chromatin changes are found only on the alpha promoter even though the beta proximal promoter contains a similar E- and GC-box arrangement. Recruitment of HDAC1 is necessary and sufficient to cause repression of alpha proximal promoter activity, and the addition of Sp1 and/or Sp3 potentiates the repression. Our data suggest that suppression of the beta promoter is facilitated by Src-induced changes in the alpha promoter chromatinization mediated by a USF1-Sp1-Sp3 complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626016     DOI: 10.1074/jbc.M702885200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.

Authors:  Chuu-Yun A Wong; Hada Wuriyanghan; Yan Xie; Ming-Fong Lin; Peter W Abel; Yaping Tu
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

Review 2.  Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.

Authors:  Irwin H Gelman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

3.  Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

Authors:  Yahao Bu; Lingqiu Gao; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

4.  Cross-Phosphorylation and Interaction between Src/FAK and MAPKAP5/PRAK in Early Focal Adhesions Controls Cell Motility.

Authors:  Sheila Figel Dwyer; Irwin H Gelman
Journal:  J Cancer Biol Res       Date:  2014-05-14

5.  Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.

Authors:  Li-Wu Guo; Lingqiu Gao; Julian Rothschild; Bing Su; Irwin H Gelman
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

6.  Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.

Authors:  Muralidharan Anbalagan; Mei Sheng; Brian Fleischer; Yifang Zhang; Yuanjun Gao; Van Hoang; Margarite Matossian; Hope E Burks; Matthew E Burow; Bridgette M Collins-Burow; David Hangauer; Brian G Rowan
Journal:  Mol Cancer Res       Date:  2017-07-27       Impact factor: 5.852

7.  Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.

Authors:  Kei Suzuki; Chitose Oneyama; Hironobu Kimura; Shoji Tajima; Masato Okada
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

8.  Transcription factors, coregulators, and epigenetic marks are linearly correlated and highly redundant.

Authors:  Tobias Ahsendorf; Franz-Josef Müller; Ved Topkar; Jeremy Gunawardena; Roland Eils
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

9.  Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.

Authors:  Xiaodong Zhao; Tianyi Wang; Bo Liu; Zhenzhou Wu; Shuo Yu; Tao Wang
Journal:  Tumour Biol       Date:  2014-12-06

10.  Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.

Authors:  Danxin Wang; Huizi Chen; Kathryn M Momary; Larisa H Cavallari; Julie A Johnson; Wolfgang Sadée
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.